Gubra
GUBRA.COGubra A/S Price (GUBRA.CO)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
16,785,000
(10.6407)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, tissue research, assays, molecular pharmacology, bioanalysis, sequencing (NGS), and 2D and 3D imaging. The company was incorporated in 2008 and is based in Horsholm, Denmark. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $240-754
- Market Cap 8.48B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Henrik Blou
- IPO Date: April, 04, 2023
- Country: DK
- Currency: DKK
- Headquaters: No Data
- Employees: 260
- Revenue from each product or segment:
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|
- Revenue by Region
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|